| ProductNum | picture | CAS No. | Name and description | Size | Formula | Quick order |
|---|---|---|---|---|---|---|
| CP003276 |
|
87-89-8 |
Inositol - 99% |
0 | C6H12O6 | |
| CP000450 |
|
156925-25-6 |
Mosapride citrate dihydrate - 99% |
0 | C27H37ClFN3O12 | |
| CP003264 |
|
119413-54-6 |
Topotecan Hydrochloride - 98% |
0 | C23H23N3O5.HCL | |
| CP004187 |
|
76095-16-4 |
Enalapril maleate - 99% |
0 | C20H28N2O5.C4H4O4;C | |
| CP002607 |
|
50-65-7 |
Niclosamide - 99% |
0 | C13H8Cl2N2O4 | |
| CP003766 |
|
109581-93-3 |
Tacrolimus monohydrate - 99% |
0 | C44H69NO12.H2O | |
| CP007874 |
|
130-40-5 |
Riboflavin sodium phosphate；Riboflavin 5'-Monophosphate Sodium Salt - 73-79% |
0 | C17H20N4NAO9P.2H2O | |
| CP005113 |
|
1184-16-3 |
Adenosine 5'-(trihydrogen diphosphate), 2'-(dihydrogen phosphate), 5'→5'-ester with 3-(aminocarbonyl)-1-β-d-ribofuranosylpyridinium hydroxide, inner salt, monosodium salt - 98% |
0 | C21H28N7O17P3.NA | |
| CP005026 |
![3-[(3-Cholanidopropyl)dimethylammonio]-1-propanesulfonate](/image/8903)
|
75621-03-3 |
3-[(3-Cholanidopropyl)dimethylammonio]-1-propanesulfonate - 99% |
0 | C32H58N2O7S | |
| CP005274 |
|
97-41-6 |
Ethyl chrysanthemumate - 98% |
0 | C12H20O2 | |
| CP000004 |
|
139404-48-1 |
Tiotropium bromide - 99% |
0 | C19H22BrNO4S2.H2O | |
| CP006608 |
|
139-05-9 |
Sodium cyclohexylsulfamate - 98% |
0 | C6H12NNAO3S | |
| CP000741 |
|
24939-03-5 |
Polyinosinic acid-polycytidylic acid；P I : PC - 50% |
0 | C10H13N4O8P.C9H14N3O8P | |
| CP002118 |
|
359875-09-5 |
Maropitant citrate - 99% |
0 | C32H40N2O.C6H8O7.H2O | |
| CP007917 |
|
1405-10-3 |
Neomycin Sulphate - 600u/mg |
0 | C23H52N6O25S3 | |
| CP003346 |
|
6645-46-1 |
L-Carnitine hydrochloride - 98% |
0 | C7H16CLNO3 | |
| CP001127 |
|
220620-09-7 |
Tigecycline - 99.9% |
0 | C29H39N5O8 | |
| CP003961 |
|
83-44-3 |
Deoxycholic acid - 98% |
0 | C24H40O4 | |
| CP006745 |
|
22662-39-1 |
Rafoxanide - 99% |
0 | C19H11NO3CL2I2 | |
| CP006451 |
|
857890-39-2 |
Lenvatinib Mesylate - 99% |
0 | C22H23ClN4O7S | |
